Fact Check: Can Ivermectin and Fenbendazole Help Treat Cancer?

By Editorial Team

Ivermectin and fenbendazole, originally developed as antiparasitic drugs, are sparking hope in the fight against cancer, fueled by inspiring stories like those shared by actor Mel Gibson on The Joe Rogan Experience, where he celebrated friends’ remarkable recoveries. While these medications aren’t yet standard cancer treatments, early research is uncovering exciting potential. Scientists are encouraged by promising lab studies and are calling for more clinical trials to confirm their effectiveness and ensure safe use in humans, paving the way for innovative, accessible therapies that could transform lives.

Introduction and Context

According to a January 22, 2025 fact-check article by AFP:

"The anti-parasitic drugs ivermectin and fenbendazole are not currently recommended for cancer, but posts spread across social media touting the medications after actor Mel Gibson claimed on the Joe Rogan Experience that they cured his friends' cases of the disease. Oncology experts said that even if the drugs show promise in trials, more research is needed to establish their efficacy in humans and safe methods of consumption."



The article makes a claim that "ivermectin and fenbendazole are not currently recommended for cancer" and "more research is needed to establish their efficacy in humans".

It's important to acknowledge that preclinical studies and case reports are common starting points in the research process before moving on to larger studies.

"The cure for cancer? It all started with a single case study."

Not all cancer types are the same.

When cancer has progressed to Stage 4—especially in cases of often-incurable cancers listed under the “Palliation Only (Metastatic)” category in the table below, where standard chemotherapy is largely ineffective—repurposed drugs may play a crucial role in making a difference.
Table Courtesy of Dr. Marik and Cancer Care

Scientific Evidence and Research Status

Joe Tippens and Kevin Hennings are popular examples of individuals achieving NED (No Evidence of Disease) with repurposed drug protocols. Tippens, diagnosed with stage 4 small cell lung cancer in 2016, claimed recovery using fenbendazole, vitamin E, and CBD oil, sharing his story on his blog, which has garnered significant attention (Joe Tippens Story).

Hennings, with stage 4 colorectal cancer, reported similar success, detailing his journey on his website and podcasts, attributing recovery to ivermectin and fenbendazole (Kevin Hennings Story).

Ivermectin and Cancer

  • 2024 Baghli et al - Targeting the Mitochondrial-Stem Cell Connection in Cancer Treatment: A Hybrid Orthomolecular Protocol - First-in-the-World Ivermectin, Mebendazole and Fenbendazole Protocol in Cancer, peer-reviewed and published on Sep.19, 2024. Co-authors include Dr Paul Marik and Dr William Makis.
  • 2024 Kaur et al - Ivermectin: A Multifaceted drug with a potential beyond anti-parasitic therapy
  • 2024 Goldfarb et al - Lipid-Restricted Culture Media Reveal Unexpected Cancer Cell Sensitivities
  • (2024 Newell et al) - Therapeutic targeting of nuclear export and import receptors in cancer and their potential in combination chemotherapy
  • Oct. 2, 2023 - IVERMECTIN and CANCER, it has at least 15 anti-cancer mechanisms of action. Can Ivermectin Treat COVID-19 mRNA Vaccine Induced Turbo Cancers? - 9 Ivermectin papers reviewed
  • BLADDER CANCER - (2024 Fan et al) - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage
  • LUNG CANCER - (2024 Man-Yuan Li et al) - Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells
  • GLIOMA - (2024 Xing Hu et al) - Ivermectin as a potential therapeutic strategy for glioma
  • MULTIPLE MYELOMA - (2024 Yang Song et al) - Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma
  • OVARIAN CANCER - (2023 Jawad et al) - Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells
  • PROSTATE CANCER - (2022 Lu et al) - Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer
  • COLON CANCER - (2022, Alghamdi et al) - Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats
  • PANCREATIC CANCER - (2022 Lee et al) - Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction
  • MELANOMA - (2022 Zhang et al) - Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis
  • CERVICAL CANCER - (2022, Qabbus et al) - Ivermectin-induced cell death of cervical cancer cells in vitro a consequence of precipitate formation in culture media
  • HEPATOCELLULAR CARCINOMA - (2022 Lu et al) - Ivermectin synergizes sorafenib in hepatocellular carcinoma via targeting multiple oncogenic pathways
  • OSTEOSARCOMA - (2022 Hu et al) - Repurposing Ivermectin to augment chemotherapy’s efficacy in osteosarcoma
  • GASTRIC CANCER - (2021 Rabben et al) - Computational drug repositioning and experimental validation of ivermectin in treatment of gastric cancer
  • LEUKEMIA - (2020, de Castro et al) - Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection
  • ESOPHAGEAL SCC - (2020, Chen et al) - Ivermectin suppresses tumour growth and metastasis through degradation of PAK1 in oesophageal squamous cell carcinoma
  • CHOLANGIOCARCINOMA - (2019 Intyuod et al) - Anti-parasitic drug ivermectin exhibits potent anticancer activity against gemcitabine-resistant cholangiocarcinoma in vitro
  • BREAST CANCER STEM CELLS - (2018 Dominguez-Gomez et al) - Ivermectin as an inhibitor of cancer stem-like cells.
  • CML (CHRONIC MYELOID LEUKEMIA) - (2018 Wang et al) - Antibiotic ivermectin selectively induces apoptosis in chronic myeloid leukemia through inducing mitochondrial dysfunction and oxidative stress.
  • RENAL CELL CARCINOMA - (2017 Zhu et al) - Antibiotic ivermectin preferentially targets renal cancer through inducing mitochondrial dysfunction and oxidative damage
  • GLIOBLASTOMA - (2016 Liu et al) - Anthelmintic drug ivermectin inhibits angiogenesis, growth and survival of glioblastoma through inducing mitochondrial dysfunction and oxidative stress.

Related: 

Fenbendazole and Cancer

  • (2024 Apr, Rodrigues et al) - Repurposing mebendazole against triple-negative breast cancer CNS metastasis
  • (2024 Feb, Eid et al) - Investigating the Promising Anticancer Activity of Cetuximab and Fenbendazole Combination as Dual CBS and VEGFR-2 Inhibitors and Endowed with Apoptotic Potential
  • (2024 Feb, Park et al) - The microtubule cytoskeleton: A validated target for the development of 2-Aryl-1H-benzo[d]imidazole derivatives as potential anticancer agents
  • (2024 Jan, Matsuo et al) - Parbendazole as a promising drug for inducing differentiation of acute myeloid leukemia cells with various subtypes
  • (2023, Dec, Iragavarapu-Charyulu et al) - A novel treatment to enhance survival for end stage triple negative breast cancer using repurposed veterinary anthelmintics combined with gut‑supporting/immune enhancing molecules
  • (2023 Nov, Aliabadi et al) - In vitro and in vivo anticancer activity of mebendazole in colon cancer: a promising drug repositioning
  • (2023 Nov, Jung et al) - Fenbendazole Exhibits Differential Anticancer Effects In Vitro and In Vivo in Models of Mouse Lymphoma
  • (2023 Sep, Garg et al) - Network pharmacology and molecular docking study-based approach to explore mechanism of benzimidazole-based anthelmintics for the treatment of lung cancer
  • (2023 Jun, Mukherjee et al) - Ketogenic diet as a metabolic vehicle for enhancing the therapeutic efficacy of mebendazole and devimistat in preclinical pediatric glioma
  • (2023 Feb, Lee et al) - Benzimidazole and its derivatives as cancer therapeutics: The potential role from traditional to precision medicine

Research Gaps and Future Directions

We acknowledge that double-blind, prospective, randomized controlled trials (RCTs) are the current gold standard in medical research. However, N=1 trials, open-label studies, and real-world data offer practical alternatives. While these approaches are less rigorous than RCTs—which are costly and time-consuming—they can still provide valuable insights, particularly for rare or advanced cancers. That said, their limitations, such as the absence of control groups and potential bias, must be carefully considered.

For patients with Stage 4 or aggressive cancers, exploring all available options is crucial given the high-stakes risk-benefit ratio. In such life-and-death situations, patients should have the "right to try."

By leveraging empirical evidence, clinical observations, and objective assessments such as cancer markers and PET scans, doctors can closely monitor both the effectiveness and safety of treatments.

Conclusion and Verdicts

  • Facebook's Verdict: Partly false (source). See below.

  • OneDayMD's Verdict: Partially true with cautious optimism. Be sure to discuss with your trusted healthcare provider and carefully weigh the potential benefits against the risks.
  • Dr John Campbell's Verdict: The consistency of anecdotal outcomes, supported by plausible preclinical mechanisms, positions fenbendazole as a promising candidate for further investigation in oncology. (source 2025)
  • Health and Me Verdict: "As of now, there is no solid evidence that ivermectin can cure or even treat cancer in humans." (source, 2025)
  • Science Feedback's Verdict: Unsupported (source)

Key Takeaway

While ivermectin and fenbendazole are not yet approved as standard cancer treatments, early research has revealed promising potential. Encouraged by compelling lab results, scientists are calling for more clinical trials to validate their effectiveness and ensure safe use in humans—potentially paving the way for innovative, accessible therapies that could change lives. As always, do your own research, consult with a trusted healthcare provider, and make informed decisions based on your individual circumstances.

Comments

Post a Comment

Popular posts from this blog

Fenbendazole vs Ivermectin for Cancer: Differences and Which Is Better?

By Editorial Team
Image
Cancer patients are increasingly inquiring about the use of the anthelmintic drugs Fenbendazole (FenBen) and Ivermectin (IVM) as potential treatments for cancer. Notably, these patients typically fall into two distinct groups, neither of which represents the usual stage 1 or 2 cancer cases where conventional therapies often show promise. The first group consists of older men whose lung or prostate cancer has recurred. Having undergone conventional treatments previously without success, they express skepticism about its effectiveness this time around. The second, larger group comprises younger patients under 40 dealing with aggressive breast cancer, colorectal cancer, or lymphoma—forms of early-onset cancers that appear to lack the typical mutations observed in traditional cases. This article aims to delve into the differences between Fenbendazole and Ivermectin by examining their mechanisms of action, approved uses, and the latest research on their efficacy across various medical con...
Read more

Top 10 Cancer Fighting Supplements: Evidence Based Literature Review (2025)

By Editorial Team
Image
Are you overwhelmed by conflicting advice on cancer, diet, and supplements ? You’re not alone. With so many claims out there, it’s hard to separate fact from fiction . Can certain foods lower your cancer risk ? Are some foods increasing it without you realizing? What about vitamin and mineral supplements —do they help prevent cancer, or could they actually increase your risk ? The term " anti-cancer supplements " can be misleading. While some nutrients support the body in cancer prevention or treatment, others may interfere with therapies or even pose risks. This guide compiles over 300 scientific references on cancer, diet, and supplements—helping you navigate the facts with confidence. Understanding Supplements and Cancer: What You Should Know Dietary supplements are not regulated like medications. Unlike prescription drugs, supplements aren’t rigorously tested by the FDA for safety or effectiveness before hitting the market. Not all supplements are beneficia...
Read more

Exploring Ivermectin and Fenbendazole as Aggressive Cancer Treatments: Research, Protocols, and Controversies (2025)

By Editorial Team
Image
Introduction There is increasing interest in the potential use of Ivermectin and Fenbendazole as cancer treatments. This guide compiles key resources—including research articles, protocols, and expert insights—exploring their possible roles in cancer therapy. Ivermectin: Key Resources Informative Article and Videos June 10, 2024  - "15 minutes with Dr.Makis" - Episode 018: High Dose IVERMECTIN and CANCER 2024 Studies Baghli et al -  Targeting the Mitochondrial-Stem Cell Connection in Cancer Treatment: A Hybrid Orthomolecular Protocol .  First-in-the-World Ivermectin, Mebendazole and Fenbendazole Protocol in Cancer has been peer-reviewed and published on Sep.19, 2024. Co-authors include Dr Paul Marik and Dr William Makis. Fan et al  - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage Man-Yuan Li et al  - Ivermectin induces non-protective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells Kaur et al...
Read more

Fenbendazole Dosage for Cancer in Humans: Benefits, Risks, and Guidelines (2025)

By Editorial Team
Image
What is Fenbendazole? Fenbendazole is an anthelmintic drug commonly used to treat parasitic infections in animals. However, recent research and anecdotal reports suggest it may have potential anticancer properties in humans. How Does Fenbendazole Work for Cancer? Fenbendazole is believed to work by disrupting microtubules in cancer cells, leading to cell cycle arrest and apoptosis (cell death). Some studies suggest it may also modulate glucose metabolism, limiting cancer cell energy supply. Recommended Fenbendazole Dosage for Cancer in Humans The commonly referenced Joe Tippens Protocol suggests the following dosage: Potential Side Effects of Fenbendazole in Humans While generally considered safe, potential side effects may include: Gastrointestinal discomfort (nausea, diarrhea, bloating) Liver enzyme elevation (rare) Bone marrow suppression (rare) Safety and Precautions Medical Supervision: Always consult with a doctor, especially if combining with other treatments. Drug Interaction...
Read more

Cancer Prevention 101: I-Prevent Cancer Protocol (2025 Edition)

By Editorial Team
Image
Cancer prevention is a multifaceted endeavor, encompassing diet, lifestyle, and supplementation. The I-PREVENT CANCER protocol offers evidence-based strategies to mitigate cancer risk. Source: AACR Cancer Progress Report 2024 Understanding Cancer and Its Causes Cancer arises from genetic mutations influenced by lifestyle and environmental factors. Diet, physical inactivity, tobacco use, and exposure to carcinogens significantly contribute to cancer development. ​ Dietary Approaches for Cancer Prevention Adopting a plant-based or Mediterranean diet can reduce cancer risk. These diets emphasize fruits, vegetables, whole grains, and healthy fats while limiting processed foods, sugars, and alcohol. Such nutritional choices provide essential antioxidants and nutrients that support cellular health. ​ Lifestyle Modifications Key lifestyle changes include: ​ Smoking Cessation : Eliminates exposure to numerous carcinogens. ​ Weight Management : Maintains hormonal balance and reduc...
Read more

Fenbendazole and Ivermectin for Cancer Case Series: Over 100 Case Reports (2025)

By Editorial Team
Image
  Contents: Editor's Preface Introduction Fenbendazole and Ivermectin Case Series Compilation (alphabetical) Breast Cancer Success Stories (13 cases) Brain Cancer (including Glioblastoma) Bile Duct Cancer (Cholangiocarcinoma) Bladder Cancer Success Stories (5 cases) Cervical Cancer Colorectal Cancer (12 cases) Esophageal and Stomach cancer Endometrial Cancer (4 cases) Gastric (Stomach) cancer (3 cases) Head and Neck Cancer (7 cases) Kidney Cancer Case Series (8 cases) Liver Cancer (2 cases) Lung Cancer (11 cases) Leukemia (2 cases) Lymphoma (4 cases) Melanoma (Skin Cancer) Multiple Myeloma Myelodysplastic Syndrome Oral Cancer Ovarian Cancer (2 cases) Pancreatic Cancer (10 cases) Prostate Cancer (15 cases) Sarcoma (2 cases) Skin Cancer (8 cases) Thymus cancer Turbo Cancer Uterine cancer Conclusion Editor's Preface We began this article with just a handful of cases, but it has since expanded to include over 100 case reports from diverse sources. “The cure for cancer? It all start...
Read more

Fenbendazole and Metastatic Cancer: the 2021 Stanford University Case Series

By Editorial Team
Image
What is the "Stanford Fenbendazole Protocol"? I bet you've never heard of the "Stanford Fenbendazole Protocol" for treating Cancer. Yet, it exists. But it's heavily suppressed by search engines and mainstream Oncology, especially in the United States and Canada. In 2021 a group at Stanford University Medical Center, Department of Medicine, published a Case Series (Clin. Oncol. Case Rep 2021)* on a "forbidden" repurposed drug, Fenbendazole. *Note: Clinical Oncology Case Reports is a peer-reviewed International clinical and medical oncology and cancer research Journal. Clinical Oncology Case Reports (COCR) is a high-impact multidisciplinary journal focus on the area of clinical and medical investigation. They wrote about 3 cases of Stage 4 Cancer patients who self-treated and cured their cancers.   Case 1: 63 year old man with a Stage 4 Renal Cell Carcinoma (clear cell) , a 5.3cm mass and mets to pancreas and bone, failed 3 lines of chemo. He ...
Read more

Eat These Foods to Starve Cancer Cells to Death (2025)

By Editorial Team
Image
Some people may not realize this, but many people have cancer cells in their bodies without presenting much danger. Fortunately, there are some common foods that can cut off cancer cell’s nutrient supply and starve them to death. Autopsies of individuals who died of trauma often reveal microscopic colonies of cancer cells , also known as in situ tumors. Some people call them “disease-free cancers.” For instance,  researchers  in Denmark performed autopsies on women aged 40 to 50, who  never  had cancer during their lifetime, and found that 39 percent of them had small cancerous lesions in their breasts. Only 1 percent of women in this age group would be diagnosed with breast cancer. Examination  of some men in their 60s showed that 46 percent of them had histological evidence of prostate cancer, which is consistent with the findings of the autopsy study. However, the prevalence of prostate cancer in men aged 60 to 70 is actually around 1 percent....
Read more

Ivermectin to Treat Cancer in Humans (2024)

By Editorial Team
Image
Ivermectin is a widely used antiparasitic drug that's listed on the World Health Organization's essential medicines list 1   and approved by the U.S. Food and Drug Administration. In low- and middle-income countries, ivermectin is commonly used to treat parasitic diseases including onchocerciasis (river blindness), strongyloidiasis and other diseases caused by soil-transmitted helminthiasis, or parasitic worms. 2 The drug is also used to treat scabies and lice. It's estimated that the total number of ivermectin doses distributed is equal to one-third of the world's population and, as such, "ivermectin at the usual doses (0.2–0.4 mg/kg) is considered extremely safe for use in humans." 3 Ivermectin also has demonstrated antiviral and anti-inflammatory properties and made headlines for its potential role in treating COVID-19 4  — although much of the positive press has been censored and falsely labeled misinformation. 5  Now researchers are highlighting another p...
Read more

Integrative Oncology Treatment Directory and Resource Page

By Editorial Team
Image
POPULAR Hyperthermia  Therapy Hyperthermia is defined as raising the temperature of the whole body or a part of the body above normal for a defined period of time. Scientific evidence shows hyperthermia may shrink tumors by damaging cancer cell proteins and structures within the cancer cells themselves. Hyperthermia is almost always used in conjunction with other cancer therapies.  Treatment use: Patients are usually recommended to use saunas 2-3 times per week, depending on the doctor's recommendation. Hyperthermia is a 45-minute treatment. IV Therapies Alpha Lipoic Acid IV Amino Acid IV Antioxidant Artemisinin Curcumin IV Detoxification IV Therapy (Chelation) DMSO High Dose Vitamin C Hydration Iv ...
Read more